RxDoctor Payments Data

Andrew Pedinoff

Allergy & Immunology · Skillman, NJNPI 1033116801

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,338 of the $3,095 with a category attached, or 75.5%. Novartis accounts for 75.9% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $2,611 and has fallen 92.9% since, to $187 in 2023. That places this record below the midpoint for allergy & immunology clinicians in NJ, where the typical reported total is $3,288.

$3,095in general payments, 2019–2025

Across 64 payments — averaging $48.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2K
  • GSK$340
  • AstraZeneca$137
  • Regeneron Healthcare Solutions, Inc.$87
  • Covis Pharma GmbH$62
  • Kaleo, Inc.$42
  • plus $77 from 6 others
$2,267,864in research payments, 2019–2025

Across 215 payments — averaging $10,548 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$526K
  • AstraZeneca$461K
  • Teva Pharmaceuticals USA, Inc.$417K
  • Amphastar Pharmaceuticals, Inc.$329K
  • Cipla USA Inc.$308K
  • Novartis$111K
  • plus $116K from 3 others

What the payments were for

  • Consulting fees$2,33876%
  • Food & beverage$75824%

General payments by program year

20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,095 in reported general payments places this provider in the 45th percentile of 135 allergy & immunology providers in New Jersey.

See all allergy & immunology providers in New Jersey

Other allergy & immunology in Skillman

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →